These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

759 related items for PubMed ID: 25645929

  • 1. The hippo pathway effector YAP regulates motility, invasion, and castration-resistant growth of prostate cancer cells.
    Zhang L, Yang S, Chen X, Stauffer S, Yu F, Lele SM, Fu K, Datta K, Palermo N, Chen Y, Dong J.
    Mol Cell Biol; 2015 Apr; 35(8):1350-62. PubMed ID: 25645929
    [Abstract] [Full Text] [Related]

  • 2. KIBRA promotes prostate cancer cell proliferation and motility.
    Stauffer S, Chen X, Zhang L, Chen Y, Dong J.
    FEBS J; 2016 May; 283(10):1800-11. PubMed ID: 27220053
    [Abstract] [Full Text] [Related]

  • 3. Wnt signaling promotes androgen-independent prostate cancer cell proliferation through up-regulation of the hippo pathway effector YAP.
    Seo WI, Park S, Gwak J, Ju BG, Chung JI, Kang PM, Oh S.
    Biochem Biophys Res Commun; 2017 May 13; 486(4):1034-1039. PubMed ID: 28366633
    [Abstract] [Full Text] [Related]

  • 4. Angiomotin regulates prostate cancer cell proliferation by signaling through the Hippo-YAP pathway.
    Zeng H, Ortiz A, Shen PF, Cheng CJ, Lee YC, Yu G, Lin SC, Creighton CJ, Yu-Lee LY, Lin SH.
    Oncotarget; 2017 Feb 07; 8(6):10145-10160. PubMed ID: 28052036
    [Abstract] [Full Text] [Related]

  • 5. Expression of netrin-1 by hypoxia contributes to the invasion and migration of prostate carcinoma cells by regulating YAP activity.
    Chen H, Chen Q, Luo Q.
    Exp Cell Res; 2016 Dec 10; 349(2):302-309. PubMed ID: 27815019
    [Abstract] [Full Text] [Related]

  • 6. Enrichment of putative prostate cancer stem cells after androgen deprivation: upregulation of pluripotency transactivators concurs with resistance to androgen deprivation in LNCaP cell lines.
    Seiler D, Zheng J, Liu G, Wang S, Yamashiro J, Reiter RE, Huang J, Zeng G.
    Prostate; 2013 Sep 10; 73(13):1378-90. PubMed ID: 23728788
    [Abstract] [Full Text] [Related]

  • 7. CD44 Promotes Migration and Invasion of Docetaxel-Resistant Prostate Cancer Cells Likely via Induction of Hippo-Yap Signaling.
    Lai CJ, Lin CY, Liao WY, Hour TC, Wang HD, Chuu CP.
    Cells; 2019 Mar 30; 8(4):. PubMed ID: 30935014
    [Abstract] [Full Text] [Related]

  • 8. The miRNAs 203a/210-3p/5001-5p regulate the androgen/androgen receptor/YAP-induced migration in prostate cancer cells.
    Huo C, Kuo YY, Lin CY, Shiah SG, Li CY, Huang SP, Chen JK, Wang WC, Kung HJ, Chuu CP.
    Cancer Med; 2024 Aug 30; 13(16):e70106. PubMed ID: 39149855
    [Abstract] [Full Text] [Related]

  • 9. miR-302/367/LATS2/YAP pathway is essential for prostate tumor-propagating cells and promotes the development of castration resistance.
    Guo Y, Cui J, Ji Z, Cheng C, Zhang K, Zhang C, Chu M, Zhao Q, Yu Z, Zhang Y, Fang YX, Gao WQ, Zhu HH.
    Oncogene; 2017 Nov 09; 36(45):6336-6347. PubMed ID: 28745315
    [Abstract] [Full Text] [Related]

  • 10. Hippo signaling promotes JNK-dependent cell migration.
    Ma X, Wang H, Ji J, Xu W, Sun Y, Li W, Zhang X, Chen J, Xue L.
    Proc Natl Acad Sci U S A; 2017 Feb 21; 114(8):1934-1939. PubMed ID: 28174264
    [Abstract] [Full Text] [Related]

  • 11. Elevated expression of Par3 promotes prostate cancer metastasis by forming a Par3/aPKC/KIBRA complex and inactivating the hippo pathway.
    Zhou PJ, Xue W, Peng J, Wang Y, Wei L, Yang Z, Zhu HH, Fang YX, Gao WQ.
    J Exp Clin Cancer Res; 2017 Oct 10; 36(1):139. PubMed ID: 29017577
    [Abstract] [Full Text] [Related]

  • 12. Interplay of mevalonate and Hippo pathways regulates RHAMM transcription via YAP to modulate breast cancer cell motility.
    Wang Z, Wu Y, Wang H, Zhang Y, Mei L, Fang X, Zhang X, Zhang F, Chen H, Liu Y, Jiang Y, Sun S, Zheng Y, Li N, Huang L.
    Proc Natl Acad Sci U S A; 2014 Jan 07; 111(1):E89-98. PubMed ID: 24367099
    [Abstract] [Full Text] [Related]

  • 13. Signal transduction pathways in androgen-dependent and -independent prostate cancer cell proliferation.
    Ghosh PM, Malik SN, Bedolla RG, Wang Y, Mikhailova M, Prihoda TJ, Troyer DA, Kreisberg JI.
    Endocr Relat Cancer; 2005 Mar 07; 12(1):119-34. PubMed ID: 15788644
    [Abstract] [Full Text] [Related]

  • 14. The Hippo Pathway in Prostate Cancer.
    Salem O, Hansen CG.
    Cells; 2019 Apr 23; 8(4):. PubMed ID: 31018586
    [Abstract] [Full Text] [Related]

  • 15. YAP is closely correlated with castration-resistant prostate cancer, and downregulation of YAP reduces proliferation and induces apoptosis of PC-3 cells.
    Sheng X, Li WB, Wang DL, Chen KH, Cao JJ, Luo Z, He J, Li MC, Liu WJ, Yu C.
    Mol Med Rep; 2015 Oct 23; 12(4):4867-76. PubMed ID: 26126522
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of ERK1/2 down-regulates the Hippo/YAP signaling pathway in human NSCLC cells.
    You B, Yang YL, Xu Z, Dai Y, Liu S, Mao JH, Tetsu O, Li H, Jablons DM, You L.
    Oncotarget; 2015 Feb 28; 6(6):4357-68. PubMed ID: 25738359
    [Abstract] [Full Text] [Related]

  • 17. FFAR1-and FFAR4-dependent activation of Hippo pathway mediates DHA-induced apoptosis of androgen-independent prostate cancer cells.
    Wang J, Hong Y, Shao S, Zhang K, Hong W.
    Biochem Biophys Res Commun; 2018 Nov 30; 506(3):590-596. PubMed ID: 30366669
    [Abstract] [Full Text] [Related]

  • 18. MYBL2 disrupts the Hippo-YAP pathway and confers castration resistance and metastatic potential in prostate cancer.
    Li Q, Wang M, Hu Y, Zhao E, Li J, Ren L, Wang M, Xu Y, Liang Q, Zhang D, Lai Y, Liu S, Peng X, Zhu C, Ye L.
    Theranostics; 2021 Nov 30; 11(12):5794-5812. PubMed ID: 33897882
    [Abstract] [Full Text] [Related]

  • 19. Statin suppresses Hippo pathway-inactivated malignant mesothelioma cells and blocks the YAP/CD44 growth stimulatory axis.
    Tanaka K, Osada H, Murakami-Tonami Y, Horio Y, Hida T, Sekido Y.
    Cancer Lett; 2017 Jan 28; 385():215-224. PubMed ID: 27773750
    [Abstract] [Full Text] [Related]

  • 20. MiR-221 expression affects invasion potential of human prostate carcinoma cell lines by targeting DVL2.
    Zheng C, Yinghao S, Li J.
    Med Oncol; 2012 Jun 28; 29(2):815-22. PubMed ID: 21487968
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.